Benzgalantamine 10 mg Delayed Release Oral Tablet
RxNorm 2690640
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2690640 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: benzgalantamine 10 mg Delayed Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Benzgalantamine 10 mg Delayed Release Oral Tablet
(Atom ID: 12908035)
SYPrescribable
Synonym (SY):
Benzgalantamine 10 mg (equivalent to benzgalantamine gluconate 14.98 mg) Delayed Release Oral Tablet
(Atom ID: 12908040)
PSNPrescribable
Prescribable Name (PSN):
Benzgalantamine 10 mg Delayed Release Oral Tablet
(Atom ID: 12908041)
Patient Education
Benzgalantamine
Benzgalantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Benzgalantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Benzgalantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, benzgalantamine will not cure AD or prevent the loss of mental abilities at some time in the future.
[Learn More]
* Please review the disclaimer below.